177 related articles for article (PubMed ID: 30573979)
1. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Sun T; Tang Y; Sun D; Bu Q; Li P
Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979
[TBL] [Abstract][Full Text] [Related]
2. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
Li J; Chen X; Dai M; Huang S; Chen J; Dai S
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):543-553. PubMed ID: 28291627
[TBL] [Abstract][Full Text] [Related]
4. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
Xu C; Yan Z; Zhou L; Wang Y
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
[TBL] [Abstract][Full Text] [Related]
7. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
Zhou Y; Yin X; Ying J; Zhang B
BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
Jia X; Liu J; Gao Y; Huang Y; Du Z
Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
[TBL] [Abstract][Full Text] [Related]
10. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
12. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
13. Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
Song H; Wang J; Zhang H; Wu Y; Wang K; Wang X; Xu X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):131-139. PubMed ID: 38310085
[TBL] [Abstract][Full Text] [Related]
14. Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Shang S; Plymoth A; Ge S; Feng Z; Rosen HR; Sangrajrang S; Hainaut P; Marrero JA; Beretta L
Hepatology; 2012 Feb; 55(2):483-90. PubMed ID: 21953299
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.
Li Z; Mou L; Gao H; Zeng Y; Tang X; Deng X; Pu Z; Ni Y; Zhan Y
Medicine (Baltimore); 2019 Aug; 98(32):e16725. PubMed ID: 31393380
[TBL] [Abstract][Full Text] [Related]
16. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Gan Y; Liang Q; Song X
Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.
Wang X; Zhang Y; Yang N; He H; Tao X; Kou C; Jiang J
Biomed Res Int; 2020; 2020():5087643. PubMed ID: 33015170
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]